Literature DB >> 16159886

Dynamics of human protein arginine methyltransferase 1(PRMT1) in vivo.

Frank Herrmann1, Jaeho Lee, Mark T Bedford, Frank O Fackelmayer.   

Abstract

Arginine methylation is a posttranslational protein modification catalyzed by a family of protein arginine methyltransferases (PRMT), the predominant member of which is PRMT1. Despite its major role in arginine methylation of nuclear proteins, surprisingly little is known about the subcellular localization and dynamics of PRMT1. We show here that only a fraction of PRMT1 is located in the nucleus, but the protein is predominantly cytoplasmic. Fluorescence recovery after photobleaching experiments reveal that PRMT1 is highly mobile both in the cytoplasm and the nucleus. However, inhibition of methylation leads to a significant nuclear accumulation of PRMT1, concomitant with the appearance of an immobile fraction of the protein in the nucleus, but not the cytoplasm. Both the accumulation and immobility of PRMT1 is reversed when re-methylation is allowed, suggesting a mechanism where PRMT1 is trapped by unmethylated substrates such as core histones and heterogeneous nuclear ribonucleoprotein proteins until it has executed the methylation reaction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16159886     DOI: 10.1074/jbc.M502458200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  Nuclear export modulates the cytoplasmic Sir2 homologue Hst2.

Authors:  Jeanne M Wilson; Viet Q Le; Collin Zimmerman; Ronen Marmorstein; Lorraine Pillus
Journal:  EMBO Rep       Date:  2006-11-17       Impact factor: 8.807

Review 2.  Protein arginine methyltransferases: from unicellular eukaryotes to humans.

Authors:  François Bachand
Journal:  Eukaryot Cell       Date:  2007-04-27

3.  Clinical evaluation of PRMT1 gene expression in breast cancer.

Authors:  Konstantina Mathioudaki; Andreas Scorilas; Alexandros Ardavanis; Peggy Lymberi; Evangelos Tsiambas; Marina Devetzi; Aikaterini Apostolaki; Maroulio Talieri
Journal:  Tumour Biol       Date:  2011-01-13

Review 4.  Role of PRMTs in cancer: Could minor isoforms be leaving a mark?

Authors:  R Mitchell Baldwin; Alan Morettin; Jocelyn Côté
Journal:  World J Biol Chem       Date:  2014-05-26

5.  CSNK1a1 Regulates PRMT1 to Maintain the Progenitor State in Self-Renewing Somatic Tissue.

Authors:  Xiaomin Bao; Zurab Siprashvili; Brian J Zarnegar; Rajani M Shenoy; Eon J Rios; Natalie Nady; Kun Qu; Angela Mah; Daniel E Webster; Adam J Rubin; Glenn G Wozniak; Shiying Tao; Joanna Wysocka; Paul A Khavari
Journal:  Dev Cell       Date:  2017-09-21       Impact factor: 12.270

6.  Arginine methylation regulates mitochondrial gene expression in Trypanosoma brucei through multiple effector proteins.

Authors:  Christopher C Goulah; Michel Pelletier; Laurie K Read
Journal:  RNA       Date:  2006-06-14       Impact factor: 4.942

7.  Signaling from the secretory granule to the nucleus: Uhmk1 and PAM.

Authors:  Victor P Francone; Marius F Ifrim; Chitra Rajagopal; Christopher J Leddy; Yanping Wang; John H Carson; Richard E Mains; Betty A Eipper
Journal:  Mol Endocrinol       Date:  2010-06-23

8.  Methylation of the tumor suppressor protein, BRCA1, influences its transcriptional cofactor function.

Authors:  Irene Guendel; Lawrence Carpio; Caitlin Pedati; Arnold Schwartz; Christine Teal; Fatah Kashanchi; Kylene Kehn-Hall
Journal:  PLoS One       Date:  2010-06-29       Impact factor: 3.240

9.  Se-adenosyl-L-selenomethionine cofactor analogue as a reporter of protein methylation.

Authors:  Ian R Bothwell; Kabirul Islam; Yuling Chen; Weihong Zheng; Gil Blum; Haiteng Deng; Minkui Luo
Journal:  J Am Chem Soc       Date:  2012-09-04       Impact factor: 15.419

10.  Multiple nuclear localization signals function in the nuclear import of the transcription factor Nrf2.

Authors:  Melanie Theodore; Yumiko Kawai; Jianqi Yang; Yuliya Kleshchenko; Sekhar P Reddy; Fernando Villalta; Ifeanyi J Arinze
Journal:  J Biol Chem       Date:  2008-01-31       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.